Skip to content
DNDi Logo
  • DNDi INTERNATIONAL
  • DNDi JAPAN
  • DNDi LATIN AMERICA
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Menu
  • ABOUT DNDi
    • ABOUT DNDi NORTH AMERICA
    • OUR TEAM
    • BOARD OF DIRECTORS
    • OUR PUBLICATIONS
    • FINANCIALS
    • JOBS
    • Close
  • DISEASES & PROJECTS
  • ADVOCACY
  • MEDIA CENTER
  • DONATE
  • CONTACT
    • Close
  • Home

Media Center

RSS SCIENTIFIC ARTICLES

  • A four-step process for building sustainable access to diagnosis and treatment of Chagas disease
  • Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India
  • Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States

RSS PRESS RELEASES

  • The French development agency AFD renews its support for the Drugs for Neglected Diseases initiative (DNDi) in researching and developing treatments for neglected tropical diseases
  • Lack of awareness of Chagas disease in the US leading to unnecessary deaths in vulnerable immigrant communities
  • La cuvée 2018 de la ‘Vigne des Nations’ de la République et canton de Genève dédiée à DNDi en reconnaissance de son travail auprès des patients les plus négligés

RSS NEWS

  • DNDi welcomes GHIT support for a new collaboration with Mitsubishi Tanabe Pharma Corporation
  • PAHO secures significant price reductions for hepatitis C medicines
  • DNDi congratulates the TB Alliance for the FDA approval of a desperately-needed new treatment for drug-resistant forms of tuberculosis

RSS IN THE MEDIA

  • The Huffington Post: “Cory Booker introduces new bill to combat diseases of extreme poverty”
  • Health Policy Watch: “Bringing health innovations to market is key in the global fight against HIV/AIDS, malaria and tuberculosis”
  • Agence Française du Développement: “Good health for all: The 3rd way”

RSS EVENTS

  • ICID 2020
  • 13th Annual NTD Conference
  • ICASA 2019

RSS Scientific Articles

  • A four-step process for building sustainable access to diagnosis and treatment of Chagas disease
  • Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India
  • Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States
  • The diagnosis of fungal neglected tropical diseases (Fungal NTDs) and the role of investigation and laboratory tests: An expert consensus report

About DNDi

Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected patients.

Subscribe

Sign up for the E-news newsletter! By subscribing, you agree that all info submitted will be processed according to our Privacy Policy. You can unsubscribe any time.

I want to receive

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
  • Events

DNDi Worldwide

  • DNDi regional offices
  • DNDi Japan のサイトへはこちらから.
  • DNDi Latin America website
  • DNDi North America website

Donate

Support research for neglected disease treatments by making a gift

Authorize.net Seal

Charity Status

GuideStar Gold Participantnewyork-ac-seal-vertical-black-web

Social Mission Ratio

DNDi's social mission ratio

  • PRIVACY POLICY
  • TERMS OF USE
  • ACCEPTABLE USE POLICY
  • COOKIE POLICY
  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License
We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser. Read Cookie Policy. Close